Literature DB >> 8095103

Transient depletion of T cells with bright CD11a/CD18 expression from peripheral circulation during acute Kawasaki disease.

S Furukawa1, T Matsubara, K Tsuji, K Okumura, K Yabuta.   

Abstract

To clarify the activation of peripheral blood T cells in Kawasaki disease (KD) patients, we investigated whether expression of lymphocyte function-associated antigen-1 (LFA-1, CD11a/CD18) and/or intercellular adhesion molecule-1 (ICAM-1, CD54) on peripheral blood T cells increases during the acute stage. Expression of cellular adhesion molecules was measured using flow cytometry. There was a decrease in the percentage of CD3+ T cells in the bright LFA-1 alpha and LFA-1 beta population and a concomitant increase in the dim population of LFA-1 alpha and LFA-1 beta during the acute stage, in comparison with those of the convalescent stage. In addition, we observed no significant differences in ICAM-1 expression during the acute stage compared with that of the convalescent stage. In our view the present data, in conjunction with previous reports on T-cell function during acute KD, suggest that activated T cells are temporarily withdrawn from peripheral circulation during acute KD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095103     DOI: 10.1111/j.1365-3083.1993.tb02567.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease.

Authors:  J Kimura; H Takada; A Nomura; T Ohno; Y Mizuno; M Saito; K Kusuhara; T Hara
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 2.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

3.  Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease.

Authors:  Haruyuki Makata; Takashi Ichiyama; Ryutaro Uchi; Tsuyoshi Takekawa; Tomoyo Matsubara; Susumu Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08-01       Impact factor: 3.000

4.  Decreased interferon-gamma (IFN-gamma)-producing T cells in patients with acute Kawasaki disease.

Authors:  T Matsubara; K Katayama; T Matsuoka; M Fujiwara; M Koga; S Furukawa
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

5.  T cell activation profiles in Kawasaki syndrome.

Authors:  P A Brogan; V Shah; L A Clarke; M J Dillon; N Klein
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

6.  Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.

Authors:  S Furukawa; T Matsubara; Y Umezawa; T Motohashi; T Ino; K Yabuta
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183

7.  CTLA-4 (CD152) expression in peripheral blood T cells in Kawasaki disease.

Authors:  T Matsubara; R Anwar; M Fujiwara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.